Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Summary: The risk of stroke in atrial fibrillation (AF) needs to be assessed in each patient to determine the clinical and cost-effectiveness of thromboprophylaxis, with the aim of appropriate use of antithrombotic therapy. To achieve this, stroke risk factors in AF populations need to be identified and stroke risk stratification models have been devised on the basis of these risk factors. In this article, we firstly provide a systematic review of studies examining the attributable stroke risk of various clinical, demographic and echocardiographic patient characteristics in AF populations. Secondly, we performed a systematic review of published stroke risk stratification models, in terms of the results of the review of stroke risk factors and their ability to accurately discriminate between different levels of stroke risk. Thirdly, we review the health economic evidence relating to the cost-effectiveness of anticoagulation and antiplatelet therapy as thromboprophylaxis in AF patients. The studies included in the systematic review of stroke risk factors identified history of stroke or TIA, increasing age, hypertension and structural heart disease (left-ventricular dysfunction or hypertrophy) to be good predictors of stroke risk in AF patients. The evidence regarding diabetes mellitus, gender and other patient characteristics was less consistent. Three stroke risk stratification models were identified that were able to discriminate between different categories of stroke risk to at least 95% accuracy. Few models had addressed the cumulative nature of risk factors where a combination of risk factors would confer a greater risk than either factor alone. In patients at high risk of stroke, anticoagulation is cost effective, but not for those with a low risk of stroke. With the evidence available for stroke risk factors and the various alternative stroke risk stratification models, a review of these models in terms of the evidence on which they are devised and their performance in representative AF populations is important. The appropriate administration of thromboprophylaxis in AF patients would need to balance the risks and benefits of antithrombotic therapy with its cost-effectiveness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Stroke in AF Working Group attributed a RR of 1.7 (95% CI, 1.4-2.0)for stroke in patients with AF and diabetes, as well as an absolute stroke risk of 2-3.5% per year for non-anticoagulated patients in the same population.621”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [621]
In the citing paper
“The Stroke in AF Working Group attributed a RR of 1.7 (95% CI, 1.4-2.0)for stroke in patients with AF and diabetes, as well as an absolute stroke risk of 2-3.5% per year for non-anticoagulated patients in the same population.621”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [621]
Citations
Cites
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793 · cited 1×
“AF increases the risk of stroke by five-fold, and the use of anticoagulation reduces this risk by two-thirds whilst antiplatelet therapy reduces stroke by one-fifth (2, 3).”
BackgroundImpact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575 · cited 1×
“Atrial fibrillation (AF) is an independent risk factor for stroke and thromboembolism and results in an independent increase in mortality per se (1).”
BackgroundMant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Self-citationACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,348
Hylek, E. M., Evans-Molina, C., Shea, C., Henault, L. E., & Regan, S. (2007) · Circulation · doi:10.1161/circulationaha.106.653048 · Cited by 1,061
Wang, T. J., Massaro, J. M., Levy, D., Vasan, R. S., Wolf, P. A., D'Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 780
Gage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Go, A. S., Hylek, E. M., Chang, Y., Phillips, K. A., Henault, L. E., Capra, A. M., Jensvold, N. G., Selby, J. V., & Singer, D. E. (2003) · JAMA · doi:10.1001/jama.290.20.2685 · Cited by 703
Writing Committee Members, Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., et al. (2006) · Europace · doi:10.1093/europace/eul097 · Cited by 667
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
Hart, R. G., Pearce, L. A., Rothbart, R. M., McAnulty, J. H., Asinger, R. W., & Halperin, J. L. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00489-1 · Cited by 663
Authors/Task Force Members, Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 644
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Go, A. S., Halperin, J. L., & Manning, W. J. (2004) · Chest · doi:10.1378/chest.126.3_suppl.429s · Cited by 547
Hart, R. G., Pearce, L. A., McBride, R., Rothbart, R. M., & Asinger, R. W. (1999) · Stroke · doi:10.1161/01.str.30.6.1223 · Cited by 533
Flaker, G. C., Belew, K., Beckman, K., Vidaillet, H., Kron, J., Safford, R., Mickel, M., & Barrell, P. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.06.032 · Cited by 341
Gage, B. F. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530230025025 · Cited by 329
Lakshminarayan, K., Solid, C. A., Collins, A. J., Anderson, D. C., & Herzog, C. A. (2006) · Stroke · doi:10.1161/01.str.0000230607.07928.17 · Cited by 243
Lip, G. Y. H., & Edwards, S. J. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.08.007 · Cited by 235
Self-citationHughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2007) · QJM · doi:10.1093/qjmed/hcm076 · Cited by 217
Self-citationvan Walraven, C., Hart, R. G., Wells, G. A., Petersen, P., Koudstaal, P. J., Gullov, A. L., Hellemons, B. S. P., Koefed, B. G., & Laupacis, A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.936 · Cited by 209
Risk for systemic embolization of atrial fibrillation without mitral stenosis
Cabin, H. S., Clubb, K. S., Hall, C., Perlmutter, R. A., & Feinstein, A. R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90323-s · Cited by 197
Thomson, R., Parkin, D., Eccles, M., Sudlow, M., & Robinson, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)90012-6 · Cited by 179
Lip, G. Y. H., Lane, D., Van Walraven, C., & Hart, R. G. (2006) · Stroke · doi:10.1161/01.str.0000236840.00467.84 · Cited by 155
Self-citationRole of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation
Klein, A. L., Murray, R. D., & Grimm, R. A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01178-5 · Cited by 154 · cited 1×
“Also, transoesophageal echocardiography (TOE) can also be used by specialists to help assess the risk of stroke and thromboembolism (5).”
BackgroundRisk of thromboembolic events in patients with atrial flutter
Seidl, K., Hauer, B., Schwick, N. G., Zellner, D., Zahn, R., & Senges, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00419-6 · Cited by 135
Risk factors for stroke in patients with nonrheumatic atrial fibrillation: A case-control study
Moulton, A. W., Singer, D. E., & Haas, J. S. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90008-l · Cited by 130
Petersen, P. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.4.819 · Cited by 129
Gustafsson, C., Asplund, K., Britton, M., Norrving, B., Olsson, B., & Marké, L. A. (1992) · BMJ · doi:10.1136/bmj.305.6867.1457 · Cited by 129
Transient Atrial Fibrillation Complicating Acute Inferior Myocardial Infarction
Siu, C., Jim, M., Ho, H., Miu, R. K.-M., Lee, S. W. L., Lau, C., & Tse, H. (2007) · CHEST Journal · doi:10.1378/chest.06-2733 · Cited by 128
Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation
Aronow, W. S., Gutstein, H., & Hsieh, F. Y. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90349-4 · Cited by 107
Pearce, L. A., Hart, R. G., & Halperin, J. L. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00440-x · Cited by 105
van Latum, J. C., Koudstaal, P. J., Venables, G. S., van Gijn, J., Kappelle, L. J., & Algra, A. (1995) · Stroke · doi:10.1161/01.str.26.5.801 · Cited by 104
Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation
Nakagami, H., Yamamoto, K., Ikeda, U., Mitsuhashi, T., Goto, T., & Shimada, K. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70231-5 · Cited by 98
ABC of Atrial Fibrillation: ANTITHROMBOTIC TREATMENT FOR ATRIAL FIBRILLATION
Lip, G. Y. H., & Lowe, G. D. O. (1996) · BMJ · doi:10.1136/bmj.312.7022.45 · Cited by 77
Self-citationAronow, W. S., Ahn, C., Kronzon, I., & Gutstein, H. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00247-1 · Cited by 74
Carotid Artery Stenosis in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation
Chang, Y.-J., Ryu, S.-J., & Lin, S.-K. (2002) · Cerebrovascular Diseases · doi:10.1159/000047740 · Cited by 73
Lightowlers, S., & McGuire, A. J. (1998) · Stroke · doi:10.1161/01.str.29.9.1827 · Cited by 71
Eckman, M. H., Levine, H. J., Salem, D. N., & Pauker, S. G. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.699s · Cited by 70
Stöllberger, C., Chnupa, P., Abzieher, C., Länger, T., Finsterer, J., Klem, I., Hartl, E., Wehinger, C., & Schneider, B. (2004) · Clinical Cardiology · doi:10.1002/clc.4960270111 · Cited by 61
Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation
Inoue, H., & Atarashi, H. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01105-x · Cited by 52
Desbiens, N. A. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50212.x · Cited by 38
Miyasaka, Y., Tsuji, H., Tokunaga, S., Nishiue, T., Yamada, K., Watanabe, J. A., & Iwasaka, T. (2000) · International Journal of Cardiology · doi:10.1016/s0167-5273(99)00208-9 · Cited by 28
Cantley, P., McKinstry, B., Macaulay, D., McMillan, J., & Irving, J. B. (1999) · Europe PMC (PubMed Central) · Cited by 7
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,864
Self-citationRuff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,822
Self-citation
Metadata
- Authors
- Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care
- Affiliations
- Royal College of Physicians (GB)
- Birmingham City Hospital (GB)
- Corresponding author
- Lip, Gregory Y. H.
- ORCID
- Lip, Gregory Y. H.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2008
- Volume
- 99
- Issue
- 02
- Pages
- 295-304
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2096867256
- Cited by
- 371
- References
- 43
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 6 · 2019: 11 · 2018: 18 · 2017: 18 · 2016: 19 · 2015: 25 · 2014: 23 · 2013: 52 · 2012: 60
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, stroke risk factors, stroke risk stratification, thromboprophylaxis, anticoagulation, antiplatelet therapy, cost-effectiveness, thromboembolism, hypertension, structural heart disease, left ventricular dysfunction, left ventricular hypertrophy, diabetes mellitus
- MeSH terms
- Age Factors, Aged, Algorithms, Anticoagulants, Atrial Fibrillation, Cost-Benefit Analysis, Female, Fibrinolytic Agents, Heart Diseases, Hemorrhage, Humans, Hypertension, Male, Platelet Aggregation Inhibitors, Research Design, Risk Factors, Sex Factors, Smoking, Thromboembolism, Drug Costs, Treatment Outcome, Health Care Costs, Risk Assessment, Patient Selection, Stroke, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.